clinical trials
| 3 min read
New research revealed that manufacturer-funded clinical trials deem drugs more effective than non-sponsored trials.
| 4 min read
Bristol Myers Squibb unveiled promising CAR T cell therapy data for severe autoimmune diseases from their Phase 1 clinical trial, offering hope for remission.
| 3 min read
Sulopenem becomes the first oral penem antibiotic approved in the United States, expanding non-IV treatment options for UTIs.
| 4 min read
Novartis’ iscalimab may improve troubling symptoms in patients with Sjögren’s disease, though there may be safety concerns to address.
| 4 min read
Elizabeth Laws leads Sanofi’s inflammation and immunology development pipeline to test the first oral TNFR1 inhibitor for rheumatoid arthritis and psoriasis.
| 4 min read
Merck researchers developed an effective vaccine against pneumococcal diseases.
| 3 min read
Manish Sharma led a clinical trial for a new antibody-drug conjugate that decreased tumor size in patients who had not responded to chemotherapy.
| 5 min read
Clinical trial insights refine early-stage toxicology evaluations, yielding safer medicines.
| 3 min read
An FDA advisory panel voted against recommending the psychedelic MDMA for PTSD, puncturing excitement around the drug’s potential.
| 3 min read
As an alternative to daily pills, a new RNAi drug could lower blood pressure with a twice-yearly injection.
Page 1 of 5 - 46 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
Subscribe